Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - TOTAL CURRENT ASSETS
Total Current Assets RARE - Ultragenyx Pharmaceutical Inc.
817 M
LAST VALUE
-3.85%
2 YEAR CAGR
-0.81%
5 YEAR CAGR
15.86%
10 YEAR CAGR